The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 9.21

Hodgkin Lymphoma

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2012
By Race/Ethnicity, Sex and Years Since Diagnosis
Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <20e 0 to <37e >=37g
All Races b Both Sexes 38,167 33,462 28,363 24,965 21,696 16,536 134,051 176,990 12,636 189,626
Males 20,781 17,382 14,349 12,735 10,761 8,636 70,014 91,797 6,285 98,082
Females 17,386 16,080 14,014 12,230 10,935 7,900 64,037 85,193 6,351 91,544
White b Both Sexes 31,580 28,310 24,730 22,151 19,990 15,371 115,070 155,246 13,975 169,221
Males 17,279 14,894 12,469 11,314 9,961 7,826 60,338 80,396 7,224 87,620
Females 14,301 13,416 12,261 10,837 10,029 7,545 54,732 74,850 6,751 81,601
Black b Both Sexes 4,902 3,930 2,839 2,320 1,338 954 14,649 16,783 1,005 17,788
Males 2,648 1,806 1,440 1,197 612 702 7,405 8,790 708 9,498
Females 2,254 2,124 1,399 1,123 726 252 7,244 7,993 297 8,290
Asian/
Pacific
Islander c		 Both Sexes 1,010 798 490 + + + 2,590 + + +
Males 515 404 266 + + + 1,300 + + +
Females 495 394 224 + + + 1,290 + + +
Hispanic d Both Sexes 4,206 3,162 2,559 + + + 11,603 + + +
Males 2,220 1,767 1,415 + + + 6,319 + + +
Females 1,986 1,395 1,144 + + + 5,284 + + +
Estimated prevalence percent a on January 1, 2012, of the SEERc population diagnosed in the previous 20 years
By Age at Prevalence, Race/Ethnicity and Sex
Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 0.0365% 0.0007% 0.0103% 0.0396% 0.0643% 0.0624% 0.0440% 0.0346% 0.0326% 0.0255% 0.0364%
Males 0.0387% 0.0011% 0.0115% 0.0390% 0.0624% 0.0661% 0.0506% 0.0421% 0.0391% 0.0294% 0.0386%
Females 0.0343% 0.0003% 0.0091% 0.0403% 0.0663% 0.0587% 0.0376% 0.0279% 0.0273% 0.0232% 0.0344%
White c Both Sexes 0.0413% 0.0007% 0.0112% 0.0446% 0.0747% 0.0708% 0.0495% 0.0388% 0.0369% 0.0288% 0.0414%
Males 0.0437% 0.0010% 0.0125% 0.0431% 0.0718% 0.0744% 0.0560% 0.0473% 0.0436% 0.0332% 0.0434%
Females 0.0390% 0.0004% 0.0098% 0.0462% 0.0779% 0.0671% 0.0431% 0.0308% 0.0314% 0.0262% 0.0395%
Black c Both Sexes 0.0330% 0.0007% 0.0100% 0.0309% 0.0598% 0.0630% 0.0437% 0.0337% 0.0297% 0.0176% 0.0341%
Males 0.0347% 0.0013% 0.0100% 0.0312% 0.0581% 0.0664% 0.0559% 0.0349% 0.0415% 0.0215% 0.0366%
Females 0.0315% - 0.0101% 0.0306% 0.0613% 0.0600% 0.0332% 0.0327% 0.0214% 0.0157% 0.0319%
Asian/
Pacific
Islander c		 Both Sexes 0.0143% 0.0010% 0.0050% 0.0231% 0.0233% 0.0205% 0.0132% 0.0108% 0.0105% 0.0075% 0.0137%
Males 0.0150% 0.0014% 0.0067% 0.0254% 0.0226% 0.0203% 0.0126% 0.0134% 0.0128% 0.0103% 0.0145%
Females 0.0137% - 0.0032% 0.0209% 0.0239% 0.0206% 0.0138% 0.0087% 0.0087% 0.0058% 0.0129%
Hispanic d Both Sexes 0.0225% 0.0010% 0.0095% 0.0270% 0.0364% 0.0343% 0.0304% 0.0337% 0.0389% 0.0228% 0.0247%
Males 0.0242% 0.0013% 0.0117% 0.0278% 0.0345% 0.0362% 0.0399% 0.0360% 0.0423% 0.0412% 0.0272%
Females 0.0208% 0.0007% 0.0072% 0.0261% 0.0385% 0.0323% 0.0212% 0.0317% 0.0363% 0.0118% 0.0226%

Footnotes:

a US 2012 cancer prevalence counts are based on 2012 cancer prevalence proportions from the SEER registries and 1/1/2012 US population estimates based on the average of 2011 and 2012 population estimates from the US Bureau of the Census. Prevalence was calculated using the First Malignant Primary Only for a person.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 11 Areas and Rural Georgia

d Statistics based on NHIA for Hispanic for SEER 11 Areas and Rural Georgia.

e Maximum limited-duration prevalence: 37 years for 1975-2012 SEER 9 data; 20 years for 1992-2012 SEER 11 data (used to calculate prevalence for Hispanics and Asian Pacific Islanders).

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 37 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <37 and >=37.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.